TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/8/24 16:44 | 10/7/24 | XFOR | X4 Pharmaceuticals, Inc | DE | Health | BioPrd | Biological Products, (No Diag | Taveras Arthur | MA | O | Chief Sc | S | -43 | 0.5630 | 0 | -77 | -17 | 388 | D | ||||||||||||||
3/11/24 17:20 | 3/11/24 | XFOR | X4 Pharmaceuticals, Inc | DE | Health | BioPrd | Biological Products, (No Diag | Taveras Arthur | MA | O | Chief Sc | S | -13 | 0.8818 | 0 | -14 | -6 | 234 | D | ||||||||||||||
2/12/24 17:23 | 2/12/24 | XFOR | X4 Pharmaceuticals, Inc | DE | Health | BioPrd | Biological Products, (No Diag | Taveras Arthur | MA | O | Chief Sc | S | -1 | 1.01 | 0 | -1 | 0 | 249 | D | ||||||||||||||
11/3/23 16:39 | 11/1/23 | XFOR | X4 Pharmaceuticals, Inc | DE | Health | BioPrd | Biological Products, (No Diag | Taveras Arthur | MA | O | Chief Sc | S | -49 | 0.7300 | 0 | -68 | -21 | 249 | D | ||||||||||||||
3/13/23 16:48 | 3/10/23 | XFOR | X4 Pharmaceuticals, Inc | DE | Health | BioPrd | Biological Products, (No Diag | Taveras Arthur | MA | O | Chief Sc | S | -14 | 0.8400 | 0 | -17 | -16 | 86 | D | ||||||||||||||
2/15/23 17:13 | 2/13/23 | XFOR | X4 Pharmaceuticals, Inc | DE | Health | BioPrd | Biological Products, (No Diag | Taveras Arthur | MA | O | Chief Sc | S | -1 | 0.9300 | 0 | -1 | -1 | 103 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |